Les Noe

477 total citations
11 papers, 335 citations indexed

About

Les Noe is a scholar working on Urology, Epidemiology and Rheumatology. According to data from OpenAlex, Les Noe has authored 11 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Urology, 4 papers in Epidemiology and 3 papers in Rheumatology. Recurrent topics in Les Noe's work include Urinary Tract Infections Management (4 papers), Urinary Bladder and Prostate Research (4 papers) and Pelvic floor disorders treatments (3 papers). Les Noe is often cited by papers focused on Urinary Tract Infections Management (4 papers), Urinary Bladder and Prostate Research (4 papers) and Pelvic floor disorders treatments (3 papers). Les Noe collaborates with scholars based in United States, Netherlands and Brazil. Les Noe's co-authors include Raafat Seifeldin, Richard A. Hansen, Sudipta Bhattacharyya, Paul Just, Miguel C. Riella, Elizabeth Tschosik, Frank de Charro, Todd Williamson, S. Pezzella and Bimal V. Patel and has published in prestigious journals such as Nephrology Dialysis Transplantation, Neuro-Oncology and Clinical Therapeutics.

In The Last Decade

Les Noe

11 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Les Noe United States 10 95 72 69 68 60 11 335
Ashish Parekh United States 9 10 0.1× 44 0.6× 13 0.2× 8 0.1× 54 0.9× 13 338
A. Icks Germany 6 52 0.5× 4 0.1× 14 0.2× 51 0.8× 79 1.3× 9 372
J. F. Cosgrove United Kingdom 8 10 0.1× 18 0.3× 8 0.1× 6 0.1× 65 1.1× 19 306
Tahir Shafi Pakistan 9 133 1.4× 7 0.1× 7 0.1× 4 0.1× 41 0.7× 15 275
Nicole Lioufas Australia 8 203 2.1× 20 0.3× 30 0.4× 23 0.4× 15 364
Adolfo Hernández-Garduño Mexico 9 19 0.2× 2 0.0× 88 1.3× 18 0.3× 63 1.1× 22 295
Hicham I. Cheikh Hassan Australia 9 144 1.5× 1 0.0× 17 0.2× 14 0.2× 46 0.8× 26 346
Karen Jenkins United Kingdom 8 208 2.2× 20 0.3× 49 0.7× 39 0.7× 26 379
Tatiana Zverkova Sandström Sweden 13 35 0.4× 16 0.2× 23 0.3× 54 0.9× 33 347
Peter H. Juergensen United States 9 275 2.9× 6 0.1× 2 0.0× 76 1.1× 19 0.3× 14 354

Countries citing papers authored by Les Noe

Since Specialization
Citations

This map shows the geographic impact of Les Noe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Les Noe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Les Noe more than expected).

Fields of papers citing papers by Les Noe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Les Noe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Les Noe. The network helps show where Les Noe may publish in the future.

Co-authorship network of co-authors of Les Noe

This figure shows the co-authorship network connecting the top 25 collaborators of Les Noe. A scholar is included among the top collaborators of Les Noe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Les Noe. Les Noe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Armstrong, Terri S., Vinay K. Puduvalli, Tobias Walbert, et al.. (2019). QOLP-20. IMPACT OF GLIOBLASTOMA ON PATIENT-REPORTED SYMPTOM BURDEN AND PHYSICAL ACTIVITY ASSESSED BY CONVENTIONAL INSTRUMENTS AND A NOVEL DEVICE–BASED TECHNOLOGY. Neuro-Oncology. 21(Supplement_6). vi201–vi202. 2 indexed citations
2.
Merchant, Sanjay, et al.. (2013). Budget Impact Analysis of Tapentadol Extended Release for the Treatment of Moderate to Severe Chronic Noncancer Pain. Clinical Therapeutics. 35(5). 659–672. 12 indexed citations
3.
Zinner, Norman R., et al.. (2009). Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: An exploratory subgroup analysis. ˜The œAmerican journal of geriatric pharmacotherapy. 7(6). 373–382. 9 indexed citations
4.
Donohue, James F., Nicola A. Hanania, Ronald L. Ciubotaru, et al.. (2008). Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: A 2-week, multicenter, randomized, open-label study. Clinical Therapeutics. 30. 989–1002. 15 indexed citations
5.
Zinner, Norman R., Les Noe, Lawrence Rasouliyan, Thomas Märshall, & Raafat Seifeldin. (2008). Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER. Current Medical Research and Opinion. 24(6). 1583–1591. 22 indexed citations
6.
Just, Paul, Frank de Charro, Elizabeth Tschosik, et al.. (2008). Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrology Dialysis Transplantation. 23(7). 2365–2373. 114 indexed citations
7.
Hansen, Richard A., Raafat Seifeldin, & Les Noe. (2007). Medication Adherence in Chronic Disease: Issues in Posttransplant Immunosuppression. Transplantation Proceedings. 39(5). 1287–1300. 74 indexed citations
8.
Noe, Les, et al.. (2004). The implications of poor medication persistence with treatment for overactive bladder.. PubMed. 17(11). 54–60. 26 indexed citations
9.
Noe, Les, et al.. (2002). A Pharmacoeconomic Model Comparing Two Long-Acting Treatments for Overactive Bladder. Journal of Managed Care Pharmacy. 8(5). 343–352. 21 indexed citations
10.
11.
Noe, Les, et al.. (1999). A Pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure. Clinical Therapeutics. 21(5). 854–866. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026